EQS-Adhoc: LifeWatch AG: Annual General Meeting approves ordinary capital increase

EQS Group-Ad-hoc: LifeWatch AG / Key word(s): AGM/EGM LifeWatch AG: Annual General Meeting approves ordinary capital increase

2016-04-15 / 15:20 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement.

LifeWatch: Annual General Meeting approves ordinary capital increase

Zug/Switzerland, April 15, 2016 - LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services to the digital health market, reports that today's Ordinary Annual General Meeting approved the ordinary capital increase proposed by the Board of Directors. 66 shareholders attended the meeting in Zurich and in total 7,935,163 votes or 58.85% of the share capital were represented. The outcomes of the motions are summarized below:

- Approval of the Annual Report 2015 and the allocation of the balance sheet result 2015.

- Discharge for fiscal year 2015 was granted to Patrick Schildknecht, Thomas Rühle, Antoine Hubert, Dr. Stephan Rietiker, Mike Turchi, Stephanie Kravetz, Dominik Aronsky, Stefan Vogt und Yair Tal.

- Elections to the Board of Directors until next Ordinary Annual General Meeting 2017

- Elected: Patrick Schildknecht, Thomas Rühle, Raymond W. Cohen, Antoine Hubert, Robert Bider, Antoine Kohler and Jinsheng Dong, the latter as representative of Himalaya TMT Fonds and as recommended by the Board of Directors

- Chairman of the Board of Directors: Robert Bider

- Elected as members of the Compensation Committee: Thomas Rühle, Antoine Hubert, Raymond W. Cohen

- The Annual General Meeting did approve the proposed amendments to the Articles of Incorporation

- Ordinary Increase of the Share Capital by a maximum of CHF 6,500,000

- Amendment of Article 3bis para. 1: This motion has been changed by the Board of Directors to an amount of CHF 0.00 which was approved by a majority of shareholders.

- The Annual General Meeting did not approve the agenda item 9.1, total compensation for the Board of Directors for the financial year 2015.

- The Annual General Meeting did approve the total compensation for the Board of Directors for the financial years 2016 and 2017.

- The Annual General Meeting approved the proposed variable compensation for the financial year 2015 and the fixed compensation to the Executive Management Team for the financial year 2017.

- Election of the independent proxy: Yves Endrass, Zurich

- Election of the statutory auditors: PricewaterhouseCoopers, Zurich

For Questions: LifeWatch AG c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser Telephone: +41 43 268 32 35 / 079 410 81 88 E-Mail: investor-relations@lifewatch.com

About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solutions' company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products. For additional information, please visit www.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at http://www.irlifewatch.com/alert-service.aspx

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, the business strategy, and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL STATEMENTS OF THE ISSUER.

End of ad hoc announcement

+++++ Additional features:

Document: http://n.eqs.com/c/fncls.ssp?u=LNUXHAFNVG Document title: LifeWatch: Annual General Meeting approves ordinary capital increase

2016-04-15 News transmitted by EQS Schweiz AG. www.eqs.com - news archive: http://switzerland.eqs.com/de/News

The issuer is responsible for the contents of the release. Language: English Company: LifeWatch AG Baarerstrasse 139 6300 Zug Switzerland Phone: +41 41 728 67 78 Internet: www.lifewatch.com ISIN: CH0012815459 Valor: 811189 Listed: Regulated Unofficial Market in Berlin, Stuttgart; Open Market in Frankfurt ; SIX

End of News EQS Group News Service 454779 2016-04-15

(END) Dow Jones Newswires

   April 15, 2016 09:20 ET (13:20 GMT)- - 09 20 AM EDT 04-15-16